Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients (COVATRHUS)
Immunological Follow-up After COVID 19 Vaccination in Kidney Transplant Recipients
Sponsor: University Hospital, Strasbourg, France
Terminated
the required number of patients has been reached
Other terminated trials from University Hospital, Strasbourg, France
- Healthy Control Subjects · Apr 2025
- Cystic Fibrosis-related Diabetes · Phase PHASE4 · Jan 2025
- Diagnosed With Uretral Fibroscopy · Sep 2024
- Patients with Colorectal Cancer · Phase NA · Sep 2024
- Dermatomyositis · Phase NA · Sep 2024
See all terminations from University Hospital, Strasbourg, France
Other Kidney Transplant Recipients trials with similar outcome
This observational or N/A phase trial investigates Kidney Transplant Recipients and is currently terminated or withdrawn. University Hospital, Strasbourg, France leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Oct 2021 — Sep 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Oct 2021 [monthly]
Not Yet Recruiting
First recorded
Feb 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .